|
Volumn 22, Issue 5, 2007, Pages 686-694
|
Effect of 2-methylene-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism
|
Author keywords
Analog; Phosphorus; PTH; Secondary hyperparathyroidism; Vitamin D
|
Indexed keywords
2 METHYLENE 19 NOR 1ALPHA HYDROXYBISHOMOPREGNACALCIFEROL;
CALCITRIOL;
CALCIUM;
CALCIUM ION;
PARATHYROID HORMONE;
PHOSPHORUS;
UNCLASSIFIED DRUG;
VITAMIN D DERIVATIVE;
2 METHYLENE 19 NOR (20S) 1 ALPHA HYDROXY BISHOMOPREGNACALCIFEROL;
2-METHYLENE-19-NOR-(20S)-1 ALPHA-HYDROXY-BISHOMOPREGNACALCIFEROL;
CALCITRIOL RECEPTOR;
DIHYDROXYCOLECALCIFEROL;
DRUG DERIVATIVE;
VITAMIN;
VITAMIN D BINDING PROTEIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BINDING AFFINITY;
CALCIUM BLOOD LEVEL;
CALCIUM MOBILIZATION;
CONTROLLED STUDY;
DISEASE MODEL;
DRUG CLEARANCE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG PROTEIN BINDING;
DRUG RECEPTOR BINDING;
DRUG STRUCTURE;
FEMALE;
NONHUMAN;
PARATHYROIDECTOMY;
PHOSPHATE BLOOD LEVEL;
RAT;
SECONDARY HYPERPARATHYROIDISM;
SPRAGUE DAWLEY RAT;
UREMIA;
ANIMAL;
CALCINOSIS;
CHEMICALLY INDUCED DISORDER;
CHRONIC DISEASE;
DOSE RESPONSE;
DRUG SCREENING;
HUMAN;
METABOLISM;
PATHOLOGY;
PROTEIN BINDING;
VASCULAR DISEASE;
ANIMALS;
CALCINOSIS;
CALCITRIOL;
CALCIUM;
CHRONIC DISEASE;
DIHYDROXYCHOLECALCIFEROLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
PHOSPHORUS;
PROTEIN BINDING;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, CALCITRIOL;
UREMIA;
VASCULAR DISEASES;
VITAMIN D-BINDING PROTEIN;
VITAMINS;
|
EID: 34447517623
PISSN: 08840431
EISSN: None
Source Type: Journal
DOI: 10.1359/jbmr.070202 Document Type: Article |
Times cited : (16)
|
References (35)
|